Clinical Trials in Seattle

Showing 3601-3620 of 5,251 trials

NRC:Improving Healthcare for Cognitively Impaired Elders and Their Caregivers

NCT03289377

An multi-stage mixed-method design will be employed to obtain both qualitative and quantitative data to address two study aims: (1) Evaluate and refine the delivery Reducing Disabilities in Alzheimer's Disease (RD- AD) training to advanced practice nurses and (2) Evaluate and refine the implementation of RD-AD by advanced practice nurses in their medical settings.

Alzheimer DiseaseNurse Training

University of Washington50 participantsStarted Feb 2018

Seattle, Washington, United States

COMPLETEDPhase 2/3< 1 mile

Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I

NCT02402530

This clinical trial is being conducted to demonstrate the efficacy of neridronic acid in the treatment of pain associated with complex regional pain syndrome type I (CRPS-I). The trial is divided into 3 periods: a 60-day enrollment period, a 12-week trial period, and an extended follow-up period with visits at Month 6, Month 9, and Month 12. The extended follow-up period will be terminated for all participants after the last participant enrolled completes their Month 6 visit (Visit 9). The double-blind will be maintained throughout the 12-week trial period and extended follow-up period.

Complex Regional Pain Syndrome, Type I

Grünenthal GmbH459 participantsStarted Apr 2015

Foley, Alabama, United States • Scottsdale, Arizona, United States • Scottsdale, Arizona, United States +56 more locations

NRC:Improving Healthcare for Cognitively Impaired Elders and Their Caregivers

Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I

Find Trials by Condition in Seattle

T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin

Computerized DBT Skills Training for Suicidal and Heavy Episodic Drinkers

LINX Reflux Management System Clinical Study Protocol

Clinical Benefits of B-Flow Ultrasound

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

PF-00489791 For The Treatment Of Raynaud's

Study of the Pharmacokinetics and Pharmacodynamics of Crystalline PX-866 Tablets and Amorphous PX-866 Capsules in Healthy Volunteers

A Study in Participants With Rheumatoid Arthritis

Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM

A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection

A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes

Phase 1 and 2 Study of PX-866 and Cetuximab

Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017

Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773

Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects

International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol